Danaher cuts TB diagnosis test cartridge by 20% for high-burden countriesDanaher Corporation announced that it will reduce the price of its Cepheid's Xpert MTB/RIF Ultra diagnostic test cartridges for tuberculosi...
MSF asks Johnson & Johnson to step away from secondary patents for key TB drugMedical charity Medecins Sans Frontieres (MSF) has once again urged Johnson & Johnson (J&J) to not enforce any 'secondary' patents for its ...
TB drug deal offers short term solution, excludes high burden nations, says health advocacy group“The deal remains just a stop-gap because bedaquiline will only be available to a limited number of countries that will be included in this...
India has seen reduction in TB incidence: MandaviyaIndia has achieved a 13% reduction in TB incidence and a 15% reduction in mortality rate from 2015 to 2022, surpassing global reduction rat...
Mobile application comes in handy for healthcare workers as India chases target to reduce tuberculosis burden by 2025As per the World Health Organisation (WHO), the total number of incident TB patients (new and relapse) in 2021 in India was 19,33,381, a 19...
Viatris cuts price of TB drug by 34%The decision to cut the price will help to expand access to a critical new treatment in more than 140 countries, including India, which has...
TB Alliance in talks with government over use of new shorter BPaL RegimenIndia has the world's highest TB burden-- 2.6 million active cases and close to 450,000 deaths each year from the infectious bacterial dise...
South East Asian health ministers commit to speed up efforts to end TBThey ministers agreed to increase budgetary and human resource allocations including upfront investments required to catch-up on lost groun...
Lupin, TB Alliance join hands for new therapy for drug-resistant tuberculosisTB Alliance President and CEO Mel Spigelman said that partnering with Lupin -- a well-established manufacturer with experience delivering h...
Mumbai pharma company gets licence for breakthrough TB drugA global non-profit drug developer TB Alliance has tied up with domestic company Macleods Pharmaceuticals to develop and commercialise its ...
TB threat during Haj: Hygiene & surveillance can prevent spreadAccording to the IJID study, the holy cities of Mecca and Medina have TB incidence four times more than the national average of Saudi Arabi...
- India urged to intensify research for multi-drug resistant TB
New Delhi, March 23 (IANS) As India continues to have 24 per cent of the world's total Tuberculosis (TB) burden, the Indian Society for Cli...
TB epidemic in India larger than what was previously estimated: WHOThe Global Tuberculosis Report 2016 which was released today, however, said the number of TB deaths and incidences rate continue to fall gl...
No. of India's TB patients may be double the estimate: StudyWhile it was assumed that India's annual TB cases stands at 2.2 million a year, the study pegs this number at over 3.8 million in 2014.
India ranks 14th out of 22 countries on TB prevalenceIndia had 2.6 million cases of Tuberculosis as per the latest count and ranks 14th among 22 high TB burden countries globally.
TB a national emergency: Health Minister Harsh VardhanVardhan said that an email repository will be built up for establishing connectivity between govt & all doctors in the country to help figh...
- 1/3rd pvt sector TB drugs outside treatment recommendations: Study
At least one-third of all private sector dosages of first line TB drugs across the 10 high TB burdened countries fall outside treatment rec...